Application

19238329 · ENGINEERED BISPECIFIC MOLECULES AND METHODS OF USE

Filed 2025-06-13 · Pending The official file ↗ · Art unit 1641 · Examiner Chun Wu Dahle Typical · CPC C07K 16/2803 · Cantai Therapeutics Inc. · GREENBERG TRAURIG, LLP (BOS)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

1.2 mo

to disposition n/a

Statutes raised

103 112

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.